Clinical Trials Logo
  1. Home
  2. Agoraphobia
  3. NCT00932919

Thought Field Therapy and Cognitive Therapy for Agoraphobia

Agoraphobia Clinical Trial

Official title:
Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Clinical Trial Summary

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Clinical Trial Description

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00932919
Study type Interventional
Source Sorlandet Hospital HF
Contact
Status Completed
Phase N/A
Start date October 2006
Completion date November 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00353470 - Comparison of Psychotherapy Programs to Treat Panic Disorder Phase 3
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Completed NCT00734370 - Virtual Reality Exposure Therapy in Agoraphobic Participants N/A
Not yet recruiting NCT06315660 - VR Based Therapy to Treat Anxiety in Dual Diagnosis N/A
Completed NCT01928823 - Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia Phase 2
Completed NCT01446172 - Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia N/A
Completed NCT03684577 - Efficacy of Hypnotherapy for Agoraphobia N/A
Completed NCT01025908 - Cognitive Behavior Psychotherapy in Panic Disorder N/A
Completed NCT00202709 - Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder? N/A
Completed NCT03156556 - Improving Access to the Treatment of Anxiety and Depression Among Young Adults N/A
Recruiting NCT05510804 - Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders N/A
Recruiting NCT03885453 - Construction of a Questionnaire on Panic Disorder and Agoraphobia
Completed NCT01928810 - Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia N/A
Recruiting NCT01323556 - Mechanisms of Panic Disorders Treatment Phase 2/Phase 3
Completed NCT00576719 - Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia Phase 2
Completed NCT03925987 - Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide N/A
Completed NCT03206437 - Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli N/A